04:25 PM EDT, 08/07/2024 (MT Newswires) -- Sarepta Therapeutics ( SRPT ) reported late Wednesday its Q2 swung to non-GAAP earnings of $0.44 per diluted share from a loss of $1.01 a year earlier.

Analysts polled by Capital IQ expected earnings of $0.47.

Revenue for the quarter ended June 30 was $362.9 million, up from $261.2 million a year earlier.

Analysts surveyed by Capital IQ expected $387.8 million.

The company's shares fell past 10% in recent after-hours activity.

Price: 125.75, Change: -14.31, Percent Change: -10.22